Article
RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.
Annals of surgery - 1 Jan 2019
Brudvik Kristoffer W, Jones Robert P, Giuliante Felice, Shindoh Junichi, Passot Guillaume, Chung Michael H, Song Juhee, Li Liang, Dagenborg Vegar J, Fretland Åsmund A, Røsok Bård, De Rose Agostino M, Ardito Francesco, Edwin Bjørn, Panettieri Elena, Larocca Luigi M, Yamashita Suguru, Conrad Claudius, Aloia Thomas A, Poston Graeme J, Bjørnbeth Bjørn A, Vauthey Jean-Nicolas
Abstract excerpt
OBJECTIVE: To determine the impact of RAS mutation status on the traditional clinical score (t-CS) to predict survival after resection of colorectal liver metastases (CLM). BACKGROUND: The t-CS relies on the following factors: primary tumor nodal status, disease-free interval, number and size of CLM, and carcinoembryonic antigen level. We hypothesized that the addition of RAS mutation status could create a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.